Download Ch06 Figures

Figure 6.1 Examples of small-molecule and peptide neurotransmitters
Figure 6.1 Examples of small-molecule and peptide neurotransmitters (Part 1)
Figure 6.1 Examples of small-molecule and peptide neurotransmitters (Part 2)
Figure 6.1 Examples of small-molecule and peptide neurotransmitters (Part 3)
Figure 6.2 Acetylcholine metabolism in cholinergic nerve terminals
Box 6A Neurotoxins that Act on Postsynaptic Receptors
Figure 6.3 The structure of the nACh receptor/channel
Figure 6.3 The structure of the nACh receptor/channel (Part 1)
Figure 6.3 The structure of the nACh receptor/channel (Part 2)
Figure 6.4 The general architecture of ligand-gated receptors
Figure 6.4 The general architecture of ligand-gated receptors (Part 1)
Figure 6.4 The general architecture of ligand-gated receptors (Part 2)
Figure 6.4 The general architecture of ligand-gated receptors (Part 3)
Box 6B Myasthenia Gravis
Figure 6.5 Structure and function of metabotropic receptors
Figure 6.5 Structure and function of metabotropic receptors (Part 1)
Figure 6.5 Structure and function of metabotropic receptors (Part 2)
Figure 6.6 Glutamate synthesis and cycling between neurons and glia
Figure 6.7 NMDA and AMPA/kainate receptors
Figure 6.7 NMDA and AMPA/kainate receptors (Part 1)
Figure 6.7 NMDA and AMPA/kainate receptors (Part 2)
Figure 6.7 NMDA and AMPA/kainate receptors (Part 3)
Figure 6.8 Synthesis, release, and reuptake of the inhibitory neurotransmitters GABA and glycine
Figure 6.8 Synthesis, release, reuptake of inhibitory neurotransmitters GABA and glycine (Part 1)
Figure 6.8 Synthesis, release, reuptake of inhibitory neurotransmitters GABA and glycine (Part 2)
Figure 6.9 Ionotropic GABA receptors
Figure 6.9 Ionotropic GABA receptors (Part 1)
Figure 6.9 Ionotropic GABA receptors (Part 2)
Box 6D Excitatory Actions of GABA in the Developing Brain
Box 6D Excitatory Actions of GABA in the Developing Brain (Part 1)
Box 6D Excitatory Actions of GABA in the Developing Brain (Part 2)
Box 6D Excitatory Actions of GABA in the Developing Brain (Part 3)
Figure 6.10 The biosynthetic pathway for the catecholamine neurotransmitters
Figure 6.10 The biosynthetic pathway for the catecholamine neurotransmitters (Part 1)
Figure 6.10 The biosynthetic pathway for the catecholamine neurotransmitters (Part 2)
Figure 6.10 The biosynthetic pathway for the catecholamine neurotransmitters (Part 3)
Figure 6.10 The biosynthetic pathway for the catecholamine neurotransmitters (Part 4)
Figure 6.10 The biosynthetic pathway for the catecholamine neurotransmitters (Part 5)
Figure 6.11 Neurons and their projections containing catecholamine neurotransmitters
Figure 6.11 Neurons and their projections containing catecholamine neurotransmitters (Part 1)
Figure 6.11 Neurons and their projections containing catecholamine neurotransmitters (Part 2)
Figure 6.11 Neurons and their projections containing catecholamine neurotransmitters (Part 3)
Figure 6.12 Distribution of neurons and their projections containing histamine or serotonin
Figure 6.12 Distribution of neurons and their projections containing histamine or serotonin (Part 1)
Figure 6.12 Distribution of neurons and their projections containing histamine or serotonin (Part 2)
Figure 6.13 Synthesis of histamine and serotonin
Figure 6.13 Synthesis of histamine and serotonin (Part 1)
Figure 6.13 Synthesis of histamine and serotonin (Part 2)
Figure 6.14 Proteolytic processing of the pre-propeptides pre-proopiomelanocortin and preproenkephalin A
Figure 6.14 Proteolytic processing of the pre-propeptides pre-proopiomelanocortin and preproenkephalin A (Part 1)
Figure 6.14 Proteolytic processing of the pre-propeptides pre-proopiomelanocortin and preproenkephalin A (Part 2)
Figure 6.15 Neuropeptides usually contain between 3 and 36 amino acids
Box 6G Marijuana and the Brain
Figure 6.16 Endocannabinoid signals involved in synaptic transmission
Figure 6.16 Endocannabinoid signals involved in synaptic transmission (Part 1)
Figure 6.16 Endocannabinoid signals involved in synaptic transmission (Part 2)
Figure 6.16 Endocannabinoid signals involved in synaptic transmission (Part 3)
Figure 6.17 Endocannabinoid-mediated retrograde control of GABA release
Figure 6.17 Endocannabinoid-mediated retrograde control of GABA release (Part 1)
Figure 6.17 Endocannabinoid-mediated retrograde control of GABA release (Part 2)
Figure 6.17 Endocannabinoid-mediated retrograde control of GABA release (Part 3)
Figure 6.18 Synthesis, release, and termination of NO